Literature DB >> 20155805

Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetamine-like psychostimulants in trace amine associated receptor 1 knockout mice.

Helen N Panas1, Laurie J Lynch, Eric J Vallender, Zhihua Xie, Guo-Lin Chen, Spencer K Lynn, Thomas S Scanlan, Gregory M Miller.   

Abstract

3-Iodothyronamine (T1AM) is a metabolite of thyroid hormone. It is an agonist at trace amine-associated receptor 1 (TAAR1), a recently identified receptor involved in monoaminergic regulation and a potential novel therapeutic target. Here, T1AM was studied using rhesus monkey TAAR1 and/or human dopamine transporter (DAT) co-transfected cells, and wild-type (WT) and TAAR1 knock-out (KO) mice. The IC(50) of T1AM competition for binding of the DAT-specific radio-ligand [(3)H]CFT was highly similar in DAT cells, WT striatal synaptosomes and KO striatal synaptosomes (0.72-0.81 microM). T1AM inhibition of 10 nM [(3)H]dopamine uptake (IC(50): WT, 1.4 + or - 0.5 microM; KO, 1.2 + or - 0.4 microM) or 50 nM [(3)H]serotonin uptake (IC(50): WT, 4.5 + or - 0.6 microM; KO, 4.7 + or - 1.1 microM) in WT and KO synaptosomes was also highly similar. Unlike other TAAR1 agonists that are DAT substrates, TAAR1 signaling in response to T1AM was not enhanced in the presence of DAT as determined by CRE-luciferase assay. In vivo, T1AM induced robust hypothermia in WT and KO mice equivalently and dose dependently (maximum change degrees Celsius: 50 mg/kg at 60 min: WT -6.0 + or - 0.4, KO -5.6 + or - 1.0; and 25 mg/kg at 30 min: WT -2.7 + or - 0.4, KO -3.0 + or - 0.2). Other TAAR1 agonists including beta-phenylethylamine (beta-PEA), MDMA (3,4-methylenedioxymethamphetamine) and methamphetamine also induced significant, time-dependent thermoregulatory responses that were alike in WT and KO mice. Therefore, TAAR1 co-expression does not alter T1AM binding to DAT in vitro nor T1AM inhibition of [(3)H]monoamine uptake ex vivo, and TAAR1 agonist-induced thermoregulatory responses are TAAR1-independent. Accordingly, TAAR1-directed compounds will likely not affect thermoregulation nor are they likely to be cryogens.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20155805      PMCID: PMC3587846          DOI: 10.1002/jnr.22367

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  22 in total

Review 1.  Trace amine receptors as targets for novel therapeutics: legend, myth and fact.

Authors:  Theresa A Branchek; Thomas P Blackburn
Journal:  Curr Opin Pharmacol       Date:  2003-02       Impact factor: 5.547

2.  Trace amines: identification of a family of mammalian G protein-coupled receptors.

Authors:  B Borowsky; N Adham; K A Jones; R Raddatz; R Artymyshyn; K L Ogozalek; M M Durkin; P P Lakhlani; J A Bonini; S Pathirana; N Boyle; X Pu; E Kouranova; H Lichtblau; F Y Ochoa; T A Branchek; C Gerald
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

3.  The thyroid hormone derivative 3-iodothyronamine increases food intake in rodents.

Authors:  W S Dhillo; G A Bewick; N E White; J V Gardiner; E L Thompson; A Bataveljic; K G Murphy; D Roy; N A Patel; J N Scutt; A Armstrong; M A Ghatei; S R Bloom
Journal:  Diabetes Obes Metab       Date:  2008-07-29       Impact factor: 6.577

4.  3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone.

Authors:  Thomas S Scanlan; Katherine L Suchland; Matthew E Hart; Grazia Chiellini; Yong Huang; Paul J Kruzich; Sabina Frascarelli; Dane A Crossley; James R Bunzow; Simonetta Ronca-Testoni; Emil T Lin; Daniel Hatton; Riccardo Zucchi; David K Grandy
Journal:  Nat Med       Date:  2004-05-16       Impact factor: 53.440

5.  Cloning, expression, and functional analysis of rhesus monkey trace amine-associated receptor 6: evidence for lack of monoaminergic association.

Authors:  Zhihua Xie; Eric J Vallender; Naichen Yu; Shelli L Kirstein; Hong Yang; Mary E Bahn; Susan V Westmoreland; Gregory M Miller
Journal:  J Neurosci Res       Date:  2008-11-15       Impact factor: 4.164

6.  Cardiac effects of trace amines: pharmacological characterization of trace amine-associated receptors.

Authors:  Sabina Frascarelli; Sandra Ghelardoni; Grazia Chiellini; Romina Vargiu; Simonetta Ronca-Testoni; Thomas S Scanlan; David K Grandy; Riccardo Zucchi
Journal:  Eur J Pharmacol       Date:  2008-04-07       Impact factor: 4.432

7.  Thyroid hormone modulates glucose production via a sympathetic pathway from the hypothalamic paraventricular nucleus to the liver.

Authors:  Lars P Klieverik; Sarah F Janssen; Annelieke van Riel; Ewout Foppen; Peter H Bisschop; Mireille J Serlie; Anita Boelen; Mariëtte T Ackermans; Hans P Sauerwein; Eric Fliers; Andries Kalsbeek
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-24       Impact factor: 11.205

8.  Trace amine-associated receptor 1 as a monoaminergic modulator in brain.

Authors:  Zhihua Xie; Gregory M Miller
Journal:  Biochem Pharmacol       Date:  2009-05-29       Impact factor: 5.858

9.  A receptor mechanism for methamphetamine action in dopamine transporter regulation in brain.

Authors:  Zhihua Xie; Gregory M Miller
Journal:  J Pharmacol Exp Ther       Date:  2009-04-13       Impact factor: 4.030

10.  Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes.

Authors:  Zhihua Xie; Susan V Westmoreland; Gregory M Miller
Journal:  J Pharmacol Exp Ther       Date:  2008-02-29       Impact factor: 4.030

View more
  30 in total

1.  Avenues for the development of therapeutics that target trace amine associated receptor 1 (TAAR1).

Authors:  Gregory M Miller
Journal:  J Med Chem       Date:  2012-01-20       Impact factor: 7.446

Review 2.  The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity.

Authors:  Gregory M Miller
Journal:  J Neurochem       Date:  2011-01       Impact factor: 5.372

Review 3.  Thermoregulation as a disease tolerance defense strategy.

Authors:  Alexandria M Palaferri Schieber; Janelle S Ayres
Journal:  Pathog Dis       Date:  2016-11-03       Impact factor: 3.166

Review 4.  TAAR Agonists.

Authors:  Zhengrong Xu; Qian Li
Journal:  Cell Mol Neurobiol       Date:  2019-12-17       Impact factor: 5.046

5.  Trace Amine-Associated Receptor 1 Regulation of Methamphetamine Intake and Related Traits.

Authors:  John H Harkness; Xiao Shi; Aaron Janowsky; Tamara J Phillips
Journal:  Neuropsychopharmacology       Date:  2015-03-05       Impact factor: 7.853

6.  Effects of acute microinjections of the thyroid hormone derivative 3-iodothyronamine to the preoptic region of adult male rats on sleep, thermoregulation and motor activity.

Authors:  Thomas D James; Steven X Moffett; Thomas S Scanlan; Joseph V Martin
Journal:  Horm Behav       Date:  2013-05-20       Impact factor: 3.587

7.  In vivo effects of abused 'bath salt' constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity.

Authors:  William E Fantegrossi; Brenda M Gannon; Sarah M Zimmerman; Kenner C Rice
Journal:  Neuropsychopharmacology       Date:  2012-11-08       Impact factor: 7.853

8.  Understanding the Healthy Thyroid State in 2015.

Authors:  Dagmar Führer; Klaudia Brix; Heike Biebermann
Journal:  Eur Thyroid J       Date:  2015-05-27

9.  Evolutionary Conservation of 3-Iodothyronamine as an Agonist at the Trace Amine-Associated Receptor 1.

Authors:  Maxi Cöster; Heike Biebermann; Torsten Schöneberg; Claudia Stäubert
Journal:  Eur Thyroid J       Date:  2015-05-29

Review 10.  Drug-induced hypothermia in stroke models: does it always protect?

Authors:  Meijuan Zhang; Haiying Wang; Jinbing Zhao; Cong Chen; Rehana K Leak; Yun Xu; Peter Vosler; Jun Chen; Yanqin Gao; Feng Zhang
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-05-01       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.